Latest news
uniQure announces plan for BLA submission for AMT-130 in Huntington’s Disease
uniQure, a leading gene therapy company advancing transformative therapies for patients with severe medical needs, has announced that, during...
ARMR Sciences achieves major milestone toward overdose protection, producing first-ever anti-fentanyl immune response in humans
ARMR Sciences, a clinical-stage biodefence company developing a platform of medical countermeasures against synthetic drugs, such as fentanyl, today...
Pentixapharm announces FDA clearance of IND for phase 3 ‘panda’ study of first-in-class cardiovascular diagnostic programme
Pentixapharm, a clinical-stage biotech developing novel radiopharmaceuticals, has announced that the US Food and Drug Administration (FDA) has cleared...
Harbour BioMed announces NMPA acceptance of IND application for HBM7004 for the treatment of advanced solid tumours
Harbour BioMed, a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology...
RxDx panel companion diagnostic receives IVDR approval across multiple cancer types and therapies
Roche has announced European Union In Vitro Diagnostic Regulation (IVDR) approval of several label expansions for the Ventana MMR...
Izalontamab Brengitecan (Iza-Bren) demonstrates statistically significant and clinically meaningful improvements in overall survival and progression-free survival in patients with triple-negative breast cancer and oesophageal...
SystImmune and Bristol Myers Squibb have announced positive results from prespecified interim analyses of two phase 3 studies evaluating izalontamab...
Medable launches Agentic accelerator programme to help life sciences companies deploy agentic AI across clinical lifecycle
Medable, a leading technology platform for agentic AI-powered clinical development, has announced its Agentic accelerator programme to help life sciences...
New study reveals promising new way to find serious liver disease earlier
Predictive Health Intelligence has announced a promising new way to identify people with serious liver disease earlier, using existing...
Development of investigational Ebola vaccines to be accelerated
The Coalition for Epidemic Preparedness Innovations (CEPI) has announced that it will urgently accelerate the development of three investigational...
Levicept presented data at EULAR 2026 suggesting Levi-04 may modify disease in osteoarthritis
Levisept, a biotechnology company focused on the development of Levi-04, a first-in-class treatment for osteoarthritis (OA), presented key data...
Northway Biotech to expand global ATMP manufacturing with €61m Vilnius facility
The most advanced cell therapy infrastructure in the Baltic region is being developed in Vilnius.
Northway Biotech, a leading protein-based...
MEKanistic Therapeutics announces FDA clearance of IND for MTX-531, enabling phase 1 trials in advanced solid tumours
MEKanistic Therapeutics, a biotechnology company developing first-in-class precision medicines designed to overcome cancer resistance mechanisms, has announced that the...
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
Popular
© 2026 Pharma Press Publishing.